Who is eligible for clinical trial NCT06407232?

Participants must meet protocol criteria for Cytomegalovirus Infections. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06407232 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-06-09

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients (NCT06407232)

🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: University of Wisconsin, Madison

🩺 Plain-English Summary (8th-Grade Level)

This study is designed to assess how effective letermovir is in preventing recurrence of cytomegalovirus (CMV) infection in adult kidney or kidney/pancreas transplant recipients who are UW Health patients. Participants will be in the study for about 6 months.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (6 items).

Location: UW Hospital and Clinics — Madison, Wisconsin

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

undergone kidney or simultaneous kidney/pancreas transplant
high-risk CMV serostatus (D+/R-) at time of transplant
develop CMV viremia that necessitates treatment per our institutional protocol (enrolled in the CMV stewardship monitoring initiative)
demonstrate proven or presumptive lack of CMI, either by CMI testing or risk factor screening
able to provide informed consent to participate

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
contraindication to letermovir or its excipients
develop ganciclovir-resistant CMV infection
currently participating in any study involving the administration of a CMV vaccine or another CMV investigational agent
unable or unwilling, in the opinion of the Investigator, to comply with the protocol
pregnant or breastfeeding

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

UW Hospital and Clinics — Madison, Wisconsin

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗